Clinical Trial Update: Using TropoCells(R) Autologous Platelet-Rich Fibrin (PRF) to Treat Chronic Non-Healing Wounds [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating TropoCells Autologous Platelet-Rich Fibrin to treat chronic non-healing wounds; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds

Drugs mentioned

• Tropocells Autologous Platelet-rich Fibrin

Snippet

Sponsor: Estar Medical dba Medical Technologies, LTD | Conditions: Wound Chronic Draining, Wound Closure | Phase 2 | Status: NOT_YET_RECRUITING